James E Saxton, LCSW in Redmond, OR - Medicare Clinical Social Worker Provider

James E Saxton, LCSW is a medicare enrolled "Social Worker - Clinical" provider in Redmond, Oregon. He graduated from medical school in 1993 and has 31 years of diverse experience with area of expertise as Clinical Social Worker. He is a member of the group practice St Charles Health System Inc and his current practice location is 916 Sw 17th St Ste 202, Redmond, Oregon. You can reach out to his office (for appointments etc.) via phone at (541) 706-2768.

James E Saxton is licensed to practice in Oregon (license number L2606) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1063604858.

Contact Information

	James E Saxton, LCSW
	916 Sw 17th St Ste 202, Redmond, OR 97756-2572
	(541) 706-2768
	Not Available

Healthcare Provider's Profile

Full Name	James E Saxton
Gender	Male
Speciality	Clinical Social Worker
Experience	31 Years
Location	916 Sw 17th St Ste 202, Redmond, Oregon
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

James E Saxton graduated from medical school in 1993

NPI Data:

NPI Number: 1063604858
Provider Enumeration Date: 08/15/2007
Last Update Date: 06/17/2022

Medicare PECOS Information:

PECOS PAC ID: 5496840753
Enrollment ID: I20071001000821

Medical Identifiers

Medical identifiers for James E Saxton such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1063604858	NPI	-	NPPES
213784	Medicaid	OR

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1041C0700X	Social Worker - Clinical	L2606 (Oregon)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
St Charles Health System Inc	3870402852	150

News Archive

Trevena doses first patient in TRV027 Phase 2b trial for acute heart failure

Trevena, Inc., a clinical stage pharmaceutical company involved in the discovery and development of G-protein coupled receptor biased ligands, announced today initiation of dosing in BLAST-AHF, the Company's randomized, multi-center Phase 2b trial of TRV027 in patients with acute heart failure.

Clinical trial examines uncertainty about when to give blood transfusions after cardiac surgery

New research has shown that patients having heart surgery do not benefit if doctors wait until a patient has become substantially anaemic before giving a transfusion.

FDA awards accelerated approval to new ovarian cancer drug

The U.S. Food and Drug Administration today granted accelerated approval to Rubraca (rucaparib) to treat women with a certain type of ovarian cancer.

Fla. squeezes Medicaid spending; Colo. dispute threatens budget

Republican Gov. Rick Scott this week proposed to slash Florida's spending in the joint state-federal health insurance program for the poor by $2 billion, in part to add $1 billion to education in the next fiscal year.

Genocea Biosciences secures licensing to extensive HSV antigen patent estate

Genocea Biosciences, a leading vaccine discovery and development company, today announced that it has licensed an extensive patent estate from the University of Washington and the Fred Hutchinson Cancer Research Center for 25 pending and issued patents related to herpes simplex virus (HSV) type 2 antigens. The addition of these patents complements the novel antigens discovered by Genocea's unique and proprietary antigen discovery technology. The combination of Genocea's novel intellectual property with the patent estate from the University of Washington provides the Company with a broad compendium of HSV antigen patents.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. James E Saxton allows following entities to bill medicare on his behalf.

Entity Name	St Charles Health System Inc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1982621447 PECOS PAC ID: 3870402852 Enrollment ID: O20040112000045

News Archive

Trevena doses first patient in TRV027 Phase 2b trial for acute heart failure

Clinical trial examines uncertainty about when to give blood transfusions after cardiac surgery

New research has shown that patients having heart surgery do not benefit if doctors wait until a patient has become substantially anaemic before giving a transfusion.

FDA awards accelerated approval to new ovarian cancer drug

The U.S. Food and Drug Administration today granted accelerated approval to Rubraca (rucaparib) to treat women with a certain type of ovarian cancer.

Fla. squeezes Medicaid spending; Colo. dispute threatens budget

Genocea Biosciences secures licensing to extensive HSV antigen patent estate

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. James E Saxton is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
James E Saxton, LCSW Po Box 5579, Bend, OR 97708-5579 Ph: (541) 706-2768	James E Saxton, LCSW 916 Sw 17th St Ste 202, Redmond, OR 97756-2572 Ph: (541) 706-2768

News Archive

Trevena doses first patient in TRV027 Phase 2b trial for acute heart failure

Clinical trial examines uncertainty about when to give blood transfusions after cardiac surgery

New research has shown that patients having heart surgery do not benefit if doctors wait until a patient has become substantially anaemic before giving a transfusion.

FDA awards accelerated approval to new ovarian cancer drug

The U.S. Food and Drug Administration today granted accelerated approval to Rubraca (rucaparib) to treat women with a certain type of ovarian cancer.

Fla. squeezes Medicaid spending; Colo. dispute threatens budget

Genocea Biosciences secures licensing to extensive HSV antigen patent estate

Social Worker in Redmond, OR

Danielle Kathryn Kaplan, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 675 Sw Rimrock Way, Redmond, OR 97756 Phone: 541-383-3005
Robert James Tovey, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1379 Sw 15th St, Redmond, OR 97756 Phone: 541-548-6166 Fax: 541-548-6168
Ms. Ann L Martin, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 124 Sw 8th St, Redmond, OR 97756 Phone: 541-504-8970 Fax: 541-504-5805
Margaret Rose Beaton, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 916 Sw 17th St, Redmond, OR 97756 Phone: 541-598-6881 Fax: 541-923-1936
Mrs. Sherrie Jeanne Adams, LCSW, CADC Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2445 Sw Canal Blvd, Redmond, OR 97756 Phone: 541-330-4611
Rachel Elizabeth Delance, Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 128 W Antler Ave, Redmond, OR 97756 Phone: 541-316-5816

James E Saxton, LCSW - Medicare Clinical Social Worker in Redmond, OR

Contact Information

Healthcare Provider's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

Trevena doses first patient in TRV027 Phase 2b trial for acute heart failure

Clinical trial examines uncertainty about when to give blood transfusions after cardiac surgery

FDA awards accelerated approval to new ovarian cancer drug

Fla. squeezes Medicaid spending; Colo. dispute threatens budget

Genocea Biosciences secures licensing to extensive HSV antigen patent estate

Medicare Reassignments

Trevena doses first patient in TRV027 Phase 2b trial for acute heart failure

Clinical trial examines uncertainty about when to give blood transfusions after cardiac surgery

FDA awards accelerated approval to new ovarian cancer drug

Fla. squeezes Medicaid spending; Colo. dispute threatens budget

Genocea Biosciences secures licensing to extensive HSV antigen patent estate

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Trevena doses first patient in TRV027 Phase 2b trial for acute heart failure

Clinical trial examines uncertainty about when to give blood transfusions after cardiac surgery

FDA awards accelerated approval to new ovarian cancer drug

Fla. squeezes Medicaid spending; Colo. dispute threatens budget

Genocea Biosciences secures licensing to extensive HSV antigen patent estate

Social Worker in Redmond, OR